Appian and UiPath Partnership Unifies the Modern Workforce of People and Software Robots
RESTON, Va. and NEW YORK CITY, May 14, 2019 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN), a leader in low-code application development, and UiPath, the leading enterprise robotic process automation (RPA) software company, today announced a technology alliance to drive fast and high-impact digital automation for enterprises. The partnership includes a no-code integration between Appian and the UiPath platform that is now available on the Appian AppMarket .
The push to digitally-transform business stems from the demand for better and faster customer service, coupled with organizational pressures to increase efficiencies by optimizing processes. By working together, Appian and UiPath are making it faster and easier to deploy enterprise automation solutions that bring people, robots, and systems together. The result is improved customer experience, efficiency, and operational performance.
“Our alliance with Appian, together with bi-directional ‘no-code’ integration, enables our joint customers to easily integrate their RPA and business process management initiatives. This is delivering an end-to-end ‘automation first’ approach where robot, system, and human activities are orchestrated uniformly to deliver accelerated digital transformation,” said Param Kahlon, Chief Product Officer at UiPath. “As our customers adopt UiPath enterprise RPA technology at an unprecedented rate, the benefit of this alliance becomes even more important.”
The UiPath Enterprise RPA Platform delivers rapid automation of manual, rules-based, repetitive processes. It’s been used to automate millions of tasks for business and government organizations all over the world — improving productivity, customer experience, and employee job satisfaction.
Appian’s low-code platform takes developers from idea to application up to 20 times faster than traditional development. Appian’s powerful business process management and case management features give business process owners an easy way to integrate robotic processes into human workflows. With bots performing mundane tasks faster and more accurately than humans can, employees can focus their attention on customer interactions and other meaningful work.
“We believe companies need a simpler way to create powerful software applications,” said Malcolm Ross, Vice President of Product at Appian. “Our partnership with UiPath enables the seamless customer experience and operational efficiency that organizations need, and our low-code platform assures the fastest time-to-value in the industry.”
UiPath is leading the “automation first” era – championing one robot for every person, delivering free and open training and collaboration and enabling robots to learn new skills through AI and machine learning. Led by a commitment to bring digital era skills to more than a million people, the company’s enterprise Robotic Process Automation (RPA) platform has already automated millions of repetitive, mind-numbing tasks for business and government organizations all over the world, improving productivity, customer experience and employee job satisfaction.
Recently named by Comparably as the 6th happiest place to work and the 11th best company culture among large businesses , UiPath is one of the fastest growing and highest-valued AI enterprise software companies worldwide.
Appian provides a low-code development platform that accelerates the creation of high-impact business applications. Many of the world’s largest organizations use Appian applications to improve customer experience, achieve operational excellence, and simplify global risk management and compliance. For more information, visit www.appian.com .
For Information Contact:
Director of Media Relations, Appian
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
Abeona Therapeutics Inc.21.5.2019 14:03:09 CEST | Pressemeddelelse
Abeona Therapeutics Announces FDA Clearance of Investigational New Drug Application for ABO-202 Gene Therapy in CLN1 Disease
Invivoscribe, Inc.21.5.2019 12:02:33 CEST | Pressemeddelelse
Invivoscribe Expanding Clinical Laboratory Network Space and Testing Capabilities in San Diego, Germany, Japan, and China. Offering Comprehensive Standardized Testing for All Hematologic Malignancies
GridGain Systems21.5.2019 09:02:54 CEST | Pressemeddelelse
GridGain Joins Cloud Native Computing Foundation
IMImobile21.5.2019 09:02:54 CEST | Pressemeddelelse
Telia Norway signs partner agreement with IMImobile for Enterprise cPaaS offering
Worksoft20.5.2019 17:56:04 CEST | Pressemeddelelse
Deutsche Telecom to Showcase How Intelligent Automation is Driving Quality and Program Efficiencies for ERP Transformation
Merus N.V.20.5.2019 14:41:11 CEST | Pressemeddelelse
Merus to Present at the RBC Capital Markets 2019 Healthcare Conference
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum